Table 4: Liver-related adverse events at the end of observation.

PBC(N=226)PBC/SS(N=56)P value

Death (%)9(4.0)2(3.6)0.877
HCC (%)2(0.8)1(1.8)0.557
Liver transplantation (%)2(0.8)0(0)0.481
Liver-related adverse events (%)13(5.8)3(5.4)1.000

HCC, hepatocellular carcinoma; SS, Sjögren’s syndrome; and PBC, primary biliary cholangitis.